RVTY
REVVITY, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$150.94
−1.11%Forward multiples
Based on analyst estimates
- P/E forward
- 26.14x
- P/E 2026E
- 28.61x
- P/E 2027E
- 26.01x
- P/E 2028E
- 23.71x
- P/S forward
- 5.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- 71.88x
- PEG TTM
- 0.42x
- Price / book
- 2.33x
- Price / sales
- 5.78x
- Price / cash flow
- 26.78x
Enterprise value
- Enterprise value
- $19.2B
- EV / sales
- 6.58x
- EV / EBITDA
- 24.98x
- EV / EBIT
- 53.40x
- Market cap
- $16.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026